Clare Peckitt

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

Ian Chau, David Cunningham, David González de Castro et al. · The Lancet Oncology · 2013 · 728 citations

Medicine, Oncology, Pharmacology +13

Mismatch Repair Deficiency, Microsatellite Instability, and Survival

Elizabeth Smyth, Andrew Wotherspoon, Clare Peckitt et al. · JAMA Oncology · 2017 · 521 citations · Full text

Life Sciences, Molecular Genetics, Oncology +17

Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy

Ellen M. Donovan, Natalie Bleakley, Erica Denholm et al. · Radiotherapy and Oncology · 2007 · 478 citations

Medicine, Oncology, Radiation Oncology +11

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

Sophia Frentzas, Ève Simoneau, Victoria L. Bridgeman et al. · Nature Medicine · 2016 · 436 citations

Medicine, Cancer Biology, Oncology +16

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

Elizabeth Smyth, Matteo Fassan, David Cunningham et al. · Journal of Clinical Oncology · 2016 · 305 citations · Full text

Medicine, Oncology, Surgery +16